反应详情
EQUATION
反应方程式
REACTANTS
反应物
未命名化合物
2 次
Bucladesine
C18H24N5O8P
Uridine diphosphate galactose
C15H24N2O17P2
未命名化合物
Phorbol 12-myristate 13-acetate
C36H56O8
未命名化合物
.alpha.-D-Galactopyranose, 2-(acetylamino)-2-deoxy-
C8H15NO6
Uridine-diphosphate-N-acetylglucosamine
C17H27N3O17P2
Monobasic potassium phosphate
H2KO4P
(2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanal
C6H12O6
未命名化合物
未命名化合物
PRODUCTS
生成物
AUXILIARIES
试剂、催化剂与溶剂
PROCEDURE
实验过程
Galβ1-3GalNAcα-pNp and GalNAcα-pNp, H-7, H-8 and H-1004 were purchased from Toronto Research Chemicals, Toronto, Canada, UDP-Gal, UDP-GlcNAc, bovine milk β1-4Gal-T (defined as 5-15 units/mg in the presence of lactalbumin), buffer salts and Triton X-100, cholera toxin, dibutyryl cAMP, 8-bromo-cAMP and phorbol 12-myristate 13-acetate (PMA) and TDA were obtained from Sigma. HPLC grade KH2PO4 and acetonitrile were obtained from Fisher Scientific. UDP-6- 3H!-galactose (18.9 Ci/mmol) and UDP-6- 3H!-N-acetylglucosamine (26.8 Ci/mmol) were provided by Amersham and NEN, respectively. C18 Sep-Pak were from Millipore-Waters. Actinomycin D and cycloheximide were purchased from Calbiochem. UDP-6- 3H!-galactose (18.9 Ci/mmole) was purchased from Amersham; dimethysulfoxide (DMSO) from BDH; all-trans-retinoic acid and sodium butyrate from Aldrich; α-modified Eagle's minimum essential medium (α-MEM) and fetal calf serum from Gibco.